S&P 500   3,121.50 (+0.03%)
DOW   28,021.32 (+0.06%)
QQQ   202.99 (+0.04%)
CGC   14.57 (-4.96%)
BABA   185.85 (+0.19%)
GE   11.38 (-1.22%)
T   39.60 (+0.23%)
ACB   2.41 (-11.72%)
F   8.95 (+0.00%)
PRI   131.35 (+0.56%)
BAC   32.94 (+0.03%)
DIS   148.52 (+2.66%)
S&P 500   3,121.50 (+0.03%)
DOW   28,021.32 (+0.06%)
QQQ   202.99 (+0.04%)
CGC   14.57 (-4.96%)
BABA   185.85 (+0.19%)
GE   11.38 (-1.22%)
T   39.60 (+0.23%)
ACB   2.41 (-11.72%)
F   8.95 (+0.00%)
PRI   131.35 (+0.56%)
BAC   32.94 (+0.03%)
DIS   148.52 (+2.66%)
S&P 500   3,121.50 (+0.03%)
DOW   28,021.32 (+0.06%)
QQQ   202.99 (+0.04%)
CGC   14.57 (-4.96%)
BABA   185.85 (+0.19%)
GE   11.38 (-1.22%)
T   39.60 (+0.23%)
ACB   2.41 (-11.72%)
F   8.95 (+0.00%)
PRI   131.35 (+0.56%)
BAC   32.94 (+0.03%)
DIS   148.52 (+2.66%)
S&P 500   3,121.50 (+0.03%)
DOW   28,021.32 (+0.06%)
QQQ   202.99 (+0.04%)
CGC   14.57 (-4.96%)
BABA   185.85 (+0.19%)
GE   11.38 (-1.22%)
T   39.60 (+0.23%)
ACB   2.41 (-11.72%)
F   8.95 (+0.00%)
PRI   131.35 (+0.56%)
BAC   32.94 (+0.03%)
DIS   148.52 (+2.66%)
Log in

Bristol-Myers Squibb SEC Filings & 10K Form (NYSE:BMY)

$57.81
-0.78 (-1.33 %)
(As of 11/18/2019 01:41 PM ET)
Today's Range
$57.46
Now: $57.81
$58.53
50-Day Range
$49.15
MA: $53.86
$59.06
52-Week Range
$42.48
Now: $57.81
$59.17
Volume15.04 million shs
Average Volume13.71 million shs
Market Capitalization$94.19 billion
P/E Ratio14.53
Dividend Yield2.80%
Beta0.71

SEC Filings

Bristol-Myers Squibb (NYSE:BMY) SEC Filings

DateFilerForm TypeView
11/18/2019
9:54 AM
Bristol-Myers Squibb (Filer)
Form CERT
11/18/2019
7:30 AM
Bristol-Myers Squibb (Filer)
Form 8-A12B
11/15/2019
4:20 PM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
11/15/2019
4:20 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2019
7:00 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
7:00 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
7:00 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
7:00 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
7:00 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
8:39 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2019
7:01 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2019
7:00 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2019
7:00 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
7:00 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2019
3:46 PM
Biondi Paul (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:54 PM
Bristol-Myers Squibb (Issuer)
Vousden Karen H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:53 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:53 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:53 PM
Bristol-Myers Squibb (Issuer)
Paliwal Dinesh C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:52 PM
Bristol-Myers Squibb (Issuer)
LACY ALAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:52 PM
Bristol-Myers Squibb (Issuer)
GROBSTEIN MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:51 PM
Bristol-Myers Squibb (Issuer)
Emmens Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:51 PM
BERTOLINI ROBERT J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:51 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2019
7:01 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
4:27 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
4:17 PM
Bristol-Myers Squibb (Issuer)
Santiago Karen Murphy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
7:30 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
4:06 PM
BERTOLINI ROBERT J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2019
10:33 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2019
7:21 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
12:36 PM
Bristol-Myers Squibb (Issuer)
Santiago Karen Murphy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
12:35 PM
Bristol-Myers Squibb (Issuer)
Hirawat Samit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
4:12 PM
BERTOLINI ROBERT J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
4:12 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:22 PM
Bristol-Myers Squibb (Issuer)
Hirawat Samit (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2019
5:59 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
7:00 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2019
7:01 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2019
4:07 PM
Bristol-Myers Squibb (Issuer)
Eid Joseph (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/13/2019
10:58 AM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/13/2019
10:55 AM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/13/2019
10:51 AM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/12/2019
3:39 PM
Bristol-Myers Squibb (Issuer)
Powell Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
7:24 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
3:40 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2019
7:06 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
3:37 PM
Bristol-Myers Squibb (Issuer)
Santiago Karen Murphy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
3:36 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
4:00 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
9:43 AM
Bristol-Myers Squibb (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
05/08/2019
4:02 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
3:40 PM
Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2019
3:39 PM
Biondi Paul (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4/A
05/01/2019
8:40 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
4:24 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
7:30 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:41 PM
Bristol-Myers Squibb (Filer)
Form DEF 14A
04/25/2019
10:39 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
7:05 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2019
7:34 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2019
4:27 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2019
4:25 PM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
04/05/2019
3:32 PM
Bristol-Myers Squibb (Issuer)
Lynch Thomas J. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2019
3:24 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2019
3:22 PM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
04/02/2019
3:43 PM
Bristol-Myers Squibb (Issuer)
Vousden Karen H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:42 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:42 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
3:30 PM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
03/29/2019
2:58 PM
Bristol-Myers Squibb (Subject)
Starboard Value LP (Filed by)
Form DFAN14A
03/28/2019
3:59 PM
Bristol-Myers Squibb (Subject)
Starboard Value LP (Filed by)
Form DFAN14A
03/26/2019
6:05 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2019
6:03 AM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
03/25/2019
4:25 PM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
03/22/2019
4:20 PM
Bristol-Myers Squibb (Subject)
Starboard Value LP (Filed by)
Form DFAN14A
03/19/2019
3:56 PM
Bristol-Myers Squibb (Subject)
Starboard Value LP (Filed by)
Form DFAN14A
03/19/2019
6:04 AM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
03/19/2019
6:02 AM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
03/18/2019
4:28 PM
Bristol-Myers Squibb (Subject)
Starboard Value LP (Filed by)
Form DFAN14A
03/18/2019
4:22 PM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
03/15/2019
4:23 PM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
03/15/2019
11:31 AM
Bristol-Myers Squibb (Subject)
Starboard Value LP (Filed by)
Form DEFC14A
03/13/2019
4:20 PM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
03/13/2019
6:42 AM
Bristol-Myers Squibb (Issuer)
Elicker John E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
6:41 AM
Bristol-Myers Squibb (Issuer)
Dubow Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
6:41 AM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
6:40 AM
Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
6:39 AM
Biondi Paul (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
6:39 AM
Bancroft Charles A (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
6:38 AM
Bristol-Myers Squibb (Issuer)
von Autenried Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
6:37 AM
Bristol-Myers Squibb (Issuer)
Schmukler Louis S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
6:37 AM
Bristol-Myers Squibb (Issuer)
Santiago Karen Murphy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
6:36 AM
Bristol-Myers Squibb (Issuer)
Lynch Thomas J. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
6:35 AM
Bristol-Myers Squibb (Issuer)
LEUNG SANDRA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
6:34 AM
Bristol-Myers Squibb (Issuer)
JUDGE ANN POWELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
4:26 PM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
03/08/2019
4:20 PM
Bristol-Myers Squibb (Filed by)
CELGENE CORP /DE/ (Subject)
Form 425
03/08/2019
6:05 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
6:02 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 11/18/2019 by MarketBeat.com Staff

Featured Article: The risks of owning bonds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel